JOHN VIERLING to Hepatitis B
This is a "connection" page, showing publications JOHN VIERLING has written about Hepatitis B.
Connection Strength
2.006
-
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis. Semin Immunopathol. 2013 Jan; 35(1):1-5.
Score: 0.348
-
Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening. Am J Public Health. 2010 Apr 01; 100 Suppl 1:S118-24.
Score: 0.285
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
Score: 0.188
-
Introduction to hepatitis B transplantation. Semin Liver Dis. 2000; 20 Suppl 1:1-2.
Score: 0.142
-
Overview of hepatitis B and transplantation in the hepatitis B patient. Semin Liver Dis. 2000; 20 Suppl 1:3-6.
Score: 0.142
-
Case studies of the hepatitis B patient: a panel discussion. Semin Liver Dis. 2000; 20 Suppl 1:29-35.
Score: 0.142
-
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
Score: 0.134
-
Recurrence of viral hepatitis after liver transplantation: insights into management. Liver Transpl Surg. 1995 Sep; 1(5 Suppl 1):89-99.
Score: 0.105
-
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
Score: 0.093
-
Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012 Nov; 20(11):2999-3008.
Score: 0.085
-
Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012 Jul; 8(4):e32-9.
Score: 0.084
-
Transmission of hepatitis B virus by artificial insemination. JAMA. 1987 Feb 27; 257(8):1079-81.
Score: 0.058
-
Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy. Liver Transpl. 2001 Jun; 7(6):513-7.
Score: 0.039
-
Posttransplantation: future therapies. Semin Liver Dis. 2000; 20 Suppl 1:19-24.
Score: 0.035
-
Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology. 1998 Jan; 27(1):213-22.
Score: 0.031
-
Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment. J Pediatr. 1995 Nov; 127(5):815-8.
Score: 0.027
-
Simultaneous detection of both hepatitis B virus DNA and hepatitis C virus RNA using a combined one-step polymerase chain reaction technique. Hepatology. 1995 Apr; 21(4):901-7.
Score: 0.025
-
Molecular diagnostic techniques for viral hepatitis. Gastroenterol Clin North Am. 1994 Sep; 23(3):479-98.
Score: 0.024
-
Immunology and the liver. Hepatology. 1991 May; 13(5):977-94.
Score: 0.019